Related references
Note: Only part of the references are listed.Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector-mediated gene therapy
Victoria M. Velazquez et al.
BLOOD (2009)
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients
Erik S. Stroes et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver
Federico Mingozzi et al.
BLOOD (2007)
CD8+ T-cell responses to adeno-associated virus capsid in humans
Federico Mingozzi et al.
NATURE MEDICINE (2007)
Safe and efficient transduction of the liver after peripheral vein infusion of self-complementary AAV vector results in stable therapeutic expression of human FIX in nonhuman primates
Amit C. Nathwani et al.
BLOOD (2007)
Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation
Joseph P. Casazza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy
Haiyan Jiang et al.
BLOOD (2006)
Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection
George Makedonas et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2006)
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
Haiyan Jiang et al.
MOLECULAR THERAPY (2006)
Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid
Luk H. Vandenberghe et al.
NATURE MEDICINE (2006)
Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development
Michael R. Betts et al.
EXPERT REVIEW OF VACCINES (2006)
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Michael R. Betts et al.
BLOOD (2006)
Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation
Colin J. D. Ross et al.
HUMAN GENE THERAPY (2006)
Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response
CS Manno et al.
NATURE MEDICINE (2006)
Rapid qualitative and quantitative analysis of T-cell responses in HIV-1-infected individuals receiving successful HAART and HIV-1 sero-negative controls:: Concomitant assessment of perforin, IFN-γ and IL-4 secretion
CT Burton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2006)
Identification of mouse AAV capsid-specific CD8+ T cell epitopes
DE Sabatino et al.
MOLECULAR THERAPY (2005)
Induction of antigen-specific CD4+T-cell anergy and deletion by in vivo viral gene transfer
E Dobrzynski et al.
BLOOD (2004)
Rescue of dystrophic muscle through U7 snRNA-mediated exon skipping
A Goyenvalle et al.
SCIENCE (2004)
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
VR Arruda et al.
BLOOD (2004)
Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer
F Mingozzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno et al.
BLOOD (2003)
Prediction of MHC class I binding peptides using profile motifs
PA Reche et al.
HUMAN IMMUNOLOGY (2002)
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
RW Herzog et al.
HUMAN GENE THERAPY (2002)
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
JD Mount et al.
BLOOD (2002)
Dynamics of T cell responses in HIV infection
V Appay et al.
JOURNAL OF IMMUNOLOGY (2002)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
MA Kay et al.
NATURE GENETICS (2000)
Share Paper
